Table 2.
Drug | Dosing information | Side effects | Precautions |
---|---|---|---|
| |||
Non-pharmacological treatments | |||
Withdraw exacerbating medications | Stop drugs that decrease blood volume or directly increase heart rate | ||
Increased oral water intake | Target 2–3 L/day | Frequent urination | |
Increased oral NaCl intake | Target 8–10 g/day | Hypertension, peripheral edema | Buffered NaCl tablets/solutions if cannot be done with diet alone |
Lower body compression garments | 20–40 mmHg compression; focus on abdomen +/− legs | Can be hot, tight, and itchy | |
Exercise training | Aerobic: 30+ min 4 days/week with some leg resistance training | Will initially feel poorly/worse for up to 6 weeks | Initial recumbent exercise (rowing, recumbent cycle or swimming) |
Pharmacological treatments | 0.1 to 0.2 mg daily | Hypokalemia, edema, headache | Electrolytes must be monitored |
Blood volume expanders | |||
Fludrocortisone | |||
Desmopressin (DDAVP) | 0.1 to 0.2 mg as needed | Hyponatremia, edema | Monitor electrolytes |
Acute IV saline | 2 L Intravenous over 2–3 h | Venous thrombosis, infection | |
Chronic IV saline | 2 L given intravenously once weekly | Infection/thrombosis risk of central venous catheters | Avoid long-term use; avoid placement of central catheters |
Erythropoietin | 10,000 IU weekly | Increased risk of cardiovascular death | Monitor Hematocrit |
Heart rate inhibitors | |||
Propranolol | 10–20 mg orally up to 4 times daily | Hypotension, bradycardia, bronchospasm | Can worsen asthma or exercise tolerance |
Ivabradine | 2.5–7.5 mg orally twice daily | headaches, palpitations, hypertension, visual disturbances | |
Pyridostigmine | 30–60 mg orally up to 3 times daily | Abdominal cramps, diarrhea | Can worsen asthma |
Vasoconstrictors | |||
Midodrine | 2.5–15 mg orally 3 times daily | Headache, scalp tingling, hypertension | |
Octreotide | Long-acting intramuscular injection 10–30 mg | Nausea, stomach cramps, diarrhea | |
Methylphenidate | 10 mg orally 2–3 times a day. Last dose should be avoided before bed. | Tachycardia, insomnia, nausea, headache, dizziness | |
Sympatholytic drugs | |||
Alpha-2 adrenergic agonists, such as clonidine | 0.1–0.2 mg orally 2–3 times daily or long acting patch | Hypotension, fatigue, brain fog | |
Methyldopa | 125–250 mg orally twice daily | Hypotension, fatigue, brain fog | |
Other | |||
Modafinil | 50–200 mg orally 1–2 times daily | Tachycardia |
Modified with permission from Miller and Raj (2018).